Skip to content
TheChatArchiveThe Chat Archive
gpt-3.5-turbo-0613· OpenAIAi2 WildChat-4.8M (AI2)

improve:It was discovered that the proportion of cNK exhibited a substantial increase in…

  1. User

    improve:It was discovered that the proportion of cNK exhibited a substantial increase in fibrotic liver after IL-10 gene intervention (Figure 4A). Interestingly, IL-10 gene intervention in fibrotic mice resulted in a notable reduction in NK cells circulating in the bloodstream. The increase in cNK cells in the liver and the decrease in NK cells in peripheral blood provided a supplementary proof that IL-10 intervention promotes the accumulation of cNK cells in fibrotic liver tissue (Figure 4 B).Next, to understand whether IL-10 attracts NK cells by altering the chemokines in the fibrotic environment, liver tissue was collected to quantify several chemokines with chemotactic immune cell capabilities, including chemokine C-C motif ligand 2, C-C motif ligand 3 and C-C motif ligand 5 (CCL2, CCL3, and CCL5). Compared to normal mice, all these chemokines were significantly increased due to the occurrence of liver fibrosis, but only CCL5, a chemokine known for its specific ability to promote the development and migration of NK cells, showed an increased production after IL-10 gene treatment (Figure 4 C). These findings suggested that IL-10 gene treatment may promote cNK cell migration to fibrotic liver tissue by upregulating CCL5.

  2. Assistant

    Improvement:

    In our study, we made an interesting discovery regarding the effect of IL-10 gene intervention on cNK cells in fibrotic liver tissue. We found that there was a substantial increase in the proportion of cNK cells in the liver after IL-10 gene intervention (Figure 4A). Surprisingly, we also observed a notable reduction in circulating NK cells in the bloodstream of fibrotic mice treated with IL-10 gene intervention. This observation further supports the idea that IL-10 intervention promotes the accumulation of cNK cells in fibrotic liver tissue (Figure 4B).

    To better understand the mechanism behind this phenomenon, we examined the effect of IL-10 on the chemokines in the fibrotic liver environment. We specifically focused on chemokines with immune cell chemotactic capabilities, such as CCL2, CCL3, and CCL5. We found that compared to normal mice, all these chemokines were significantly increased in the fibrotic liver tissue. However, we only observed an increased production of CCL5 after IL-10 gene treatment (Figure 4C).

    This finding suggests that IL-10 gene treatment may promote the migration of cNK cells to fibrotic liver tissue by upregulating the production of CCL5, which is known to have a specific ability to promote the development and migration of NK cells.

  3. User

    IL-10 gene treatment promotes an increase in the number of NK cells, facilitates their activation, and enhances their cytotoxic capabilities within the fibrotic liver.

  4. Assistant

    Improvement:

    Furthermore, our study revealed that IL-10 gene treatment not only promotes the accumulation of cNK cells in fibrotic liver tissue, but also enhances their functionality. We observed an increase in the number of NK cells, their activation status, and their cytotoxic capabilities within the fibrotic liver after IL-10 gene intervention. This suggests that IL-10 plays a crucial role in modulating NK cell responses and their anti-fibrotic effects in the liver. These findings highlight the potential therapeutic implications of IL-10 gene treatment in liver fibrosis.